Geron Corporation

Symbol: GERN

NASDAQ

3.79

USD

Market price today

  • -12.2499

    P/E Ratio

  • -0.5250

    PEG Ratio

  • 2.23B

    MRK Cap

  • 0.00%

    DIV Yield

Geron Corporation (GERN) Stock Price & Analysis

Shares Outstanding

588.06M

Gross Profit Margin

-126.40%

Operating Profit Margin

-818.33%

Net Profit Margin

-776.71%

Return on Assets

-0.47%

Return on Equity

-0.63%

Return on Capital Employed

-0.68%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Dr. John A. Scarlett M.D.
Full-time employees:141
City:Foster City
Address:919 East Hillsdale Boulevard
IPO:1996-07-31
CIK:0000886744

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

General Outlook

In simple terms, Geron Corporation has 588.059 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep -126.397% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -818.329%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -776.709%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.467% return, is a testament to Geron Corporation's adeptness in optimizing resource deployment. Geron Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.633%. Furthermore, the proficiency of Geron Corporation in capital utilization is underscored by a remarkable -0.678% return on capital employed.

Stock Prices

Geron Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $3.35, while its low point bottomed out at $3.15. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Geron Corporation's stock market.

Liquidity Ratios

Analyzing GERN liquidity ratios reveals its financial health of the firm. The current ratio of 315.86% gauges short-term asset coverage for liabilities. The quick ratio (311.34%) assesses immediate liquidity, while the cash ratio (65.83%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio315.86%
Quick Ratio311.34%
Cash Ratio65.83%

Profitability Ratios

GERN profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -77691.14% underscores its earnings before tax deductions. The effective tax rate stands at -0.91%, revealing its tax efficiency. The net income per EBT, 99.97%, and the EBT per EBIT, 94.94%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -81832.91%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-77691.14%
Effective Tax Rate-0.91%
Net Income per EBT99.97%
EBT per EBIT94.94%
EBIT per Revenue-81832.91%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 3.16, it details the span from stock purchase to revenue. The 3 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 14.32% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding311
Operating Cycle2548.84
Days of Payables Outstanding74
Cash Conversion Cycle2474
Receivables Turnover0.14
Payables Turnover4.90
Fixed Asset Turnover0.05

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.28, and free cash flow per share, -0.28, depict cash generation on a per-share basis. The cash per share value, 0.56, showcases liquidity position. Lastly, the operating cash flow sales ratio, -705.08, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.28
Free Cash Flow per Share-0.28
Cash per Share0.56
Operating Cash Flow Sales Ratio-705.08
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio-2.02
Short Term Coverage Ratio-3.49
Capital Expenditure Coverage Ratio-201.33
Dividend Paid and Capex Coverage Ratio-201.33

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 21.03%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.33, we discern the balance between debt and equity financing. The long-term debt to capitalization, 12.39%, and total debt to capitalization, 25.06%, ratios shed light on its capital structure. An interest coverage of -46.40 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio21.03%
Debt Equity Ratio0.33
Long Term Debt to Capitalization12.39%
Total Debt to Capitalization25.06%
Interest Coverage-46.40
Cash Flow to Debt Ratio-2.02
Company Equity Multiplier1.59

Per Share Data

Net income per share, -0.32, reflects the portion of profit attributed to each share. The book value per share, 0.43, represents the net asset value distributed per share, while the tangible book value per share, 0.43, excludes intangible assets.

cards.indicatorcards.value
Net Income Per Share-0.32
Book Value Per Share0.43
Tangible Book Value Per Share0.43
Shareholders Equity Per Share0.43
Interest Debt Per Share0.16

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -60.23%, indicates top-line expansion, while the gross profit growth, -192.65%, reveals profitability trends. EBIT growth, -39.98%, and operating income growth, -39.98%, offer insights into operational profitability progression. The net income growth, -30.56%, showcases bottom-line expansion, and the EPS growth, 13.51%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-60.23%
Gross Profit Growth-192.65%
EBIT Growth-39.98%
Operating Income Growth-39.98%
Net Income Growth-30.56%
EPS Growth13.51%
EPS Diluted Growth13.51%
Weighted Average Shares Growth49.86%
Weighted Average Shares Diluted Growth49.86%
Operating Cash Flow Growth-31.19%
Free Cash Flow Growth-31.39%
10-Year Revenue Growth per Share-95.86%
5-Year Revenue Growth per Share-93.12%
3-Year Revenue Growth per Share-55.44%
10-Year Operating CF Growth per Share-2.13%
5-Year Operating CF Growth per Share-146.02%
3-Year Operating CF Growth per Share-19.26%
10-Year Net Income Growth per Share-7.55%
5-Year Net Income Growth per Share-110.80%
3-Year Net Income Growth per Share-15.85%
10-Year Shareholders Equity Growth per Share-6.98%
5-Year Shareholders Equity Growth per Share-56.85%
3-Year Shareholders Equity Growth per Share-44.08%
Receivables Growth-47.36%
Inventory Growth100.00%
Asset Growth106.78%
Book Value per Share Growth106.82%
Debt Growth54.07%
R&D Expense Growth30.91%
SGA Expenses Growth56.10%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,218,822,804.55, captures the company's total value, considering both debt and equity. Income quality, 0.91, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 291.71, gauges operational efficiency, while the research and development to revenue, 52762.03%, highlights investment in innovation.

cards.indicatorcards.value
Enterprise Value1,218,822,804.55
Income Quality0.91
Sales General and Administrative to Revenue291.71
Research and Development to Revenue52762.03%
Capex to Operating Cash Flow0.50%
Capex to Revenue-350.21%
Capex to Depreciation-80.35%
Stock-Based Compensation to Revenue7816.88%
Graham Number1.78
Return on Tangible Assets-46.72%
Graham Net Net0.33
Working Capital233,278,000
Tangible Asset Value247,949,000
Net Current Asset Value195,221,000
Average Receivables2,399,500
Average Payables8,175,500
Average Inventory-1,572,000
Days Sales Outstanding2549
Days Payables Outstanding2177
ROIC-58.62%
ROE-0.74%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 9.09, and the price to book ratio, 9.09, reflect the market's valuation relative to the company's book value. The price to sales ratio, 9403.98, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -13.27, and price to operating cash flows, -13.49, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio9.09
Price to Book Ratio9.09
Price to Sales Ratio9403.98
Price Cash Flow Ratio-13.49
Price Earnings to Growth Ratio-0.52
Enterprise Value Multiple-11.98
Price Fair Value9.09
Price to Operating Cash Flow Ratio-13.49
Price to Free Cash Flows Ratio-13.27
Price to Tangible Book Ratio4.86
Enterprise Value to Sales5142.71
Enterprise Value Over EBITDA-6.32
EV to Operating Cash Flow-7.29
Earnings Yield-15.29%
Free Cash Flow Yield-13.95%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Geron Corporation (GERN) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -12.250 in 2024.

What is the ticker symbol of Geron Corporation stock?

The ticker symbol of Geron Corporation stock is GERN.

What is company IPO date?

IPO date of Geron Corporation is 1996-07-31.

What is company current share price?

Current share price is 3.790 USD.

What is stock market cap today?

The market cap of stock today is 2228743610.000.

What is PEG ratio in 2024?

The current -0.525 is -0.525 in 2024.

What is the number of employees in 2024?

In 2024 the company has 141.